KIYAN MEDICAL Co., Ltd.
As an entity with a pharmaceutical company as its parent, KIYAN MEDICAL Co., Ltd. is deeply committed to contributing to society and playing a vital role in building a healthy and sustainable future.
Tokyo Head Office
“From Research and Development to Social Implementation”
DNA as a Pharmaceutical Manufacturer and R&D Enterprise
Executive Introduction
Career
Career
Career
Advisor Introduction
Career
Company History
KIYAN MEDICAL Co., Ltd. was established in October 2023 as a company dedicated to pharmaceutical manufacturing, through a collaboration between LIMNO Co., Ltd. (formerly Tottori Sanyo Group) led by Hiroyoshi Hata and KIYAN PHARMA Co., Ltd.
March 1971
The Fukuroi Factory of KIYAN PHARMA Co., Ltd. was established by Japan Roche Co., Ltd. as the world’s largest manufacturing base for vitamin B2 precursor.
May 2016
KIYAN PHARMA Co., Ltd. (formerly known as Neopharma Japan Co., Ltd.) was established.
October 2016
KIYAN PHARMA Co., Ltd. acquired the Fukuroi Factory capable of mass production of 5-Aminolevulinic Acid (5-ALA) from API Corporation.
July 2023
The board of directors at KIYAN PHARMA Co., Ltd. was restructured, with Hiroyoshi Hata assuming the role of Chairman.
October 2023
KIYAN MEDICAL Co., Ltd. was established as a wholly-owned subsidiary of KIYAN PHARMA Co., Ltd.
January 2024
Fumihisa Kojima of Biozipcode, Inc., aiming for the research, development, and application of a definitive cure for diabetes and cell targeting technology (Biozipcode), joined as a Director of our company in collaboration with Shiga University of Medical Science.
April 2024
Hideto Kojima, Distinguished Professor of the Life Information Development Course and Regenerative Medicine Development Course at Shiga University of Medical Science, joined as an Academic Advisor.
Hideto Kojima, Distinguished Professor of the Life Information Development Course and Regenerative Medicine Development Course at Shiga University of Medical Science, joined as an Academic Advisor.
About “KIYAN MEDICAL”
As a pharmaceutical “Entity”, we’re committed to contributing to a healthy, sustainable future.
Prioritizing research’s social implementation, we aim to shape medicine’s future and benefit society.
Our essence reflects our philosophy and impact on lives through our products and technologies.
KIYAN MEDICAL consistently bridges research, manufacturing, and treatment, enhancing health care.
Committed to stakeholders’ needs, we adapt to global changes, ensuring resilience and relevance.
Our mission is to enhance lives through impactful health products and services, promoting well-being.
A policy aligned with the “Act on the Protection of Personal Information” governs our handling of personal data.
